510(k) K222591

BD BACTEC™ Plus Aerobic/F Culture Vials by Becton, Dickinson And Company — Product Code MDB

K222591 is an FDA 510(k) premarket notification submitted by Becton, Dickinson And Company for the device "BD BACTEC™ Plus Aerobic/F Culture Vials". The FDA issued a decision of Substantially Equivalent on Mar 24, 2023. The device falls under product code MDB (System, Blood Culturing), a Class I device regulated under 21 CFR 866.2560. Becton, Dickinson And Company has 330 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Mar 24, 2023
Date Received
Aug 26, 2022
Clearance Type
Special
Expedited Review
No
Third Party Review
No

Device classification

Device Name
System, Blood Culturing
Device Class
Class I
Regulation Number
866.2560
Review Panel
MI
Submission Type
510(k)

Need the full FDA record for Becton, Dickinson And Company? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K222591. Report a data issue: hello@regdatalab.com.